Canadian Journal of Infectious Diseases and Medical Microbiology (Jan 2006)

An Assessment of Linezolid Utilization in Selected Canadian Provinces

  • Sandra Walker,
  • Linda Dresser,
  • Debbie Becker,
  • Alissa Scalera

DOI
https://doi.org/10.1155/2006/818535
Journal volume & issue
Vol. 17, no. 3
pp. 177 – 182

Abstract

Read online

BACKGROUND: Linezolid is approved for the treatment of designated infections caused by methicillin-resistant and -susceptible Staphylococcus aureus and vancomycin-resistant Enterococcus faecium.